𧬠Positive-Sense RNA: Core Principles
Defining logic
- Genome has the same polarity as mRNA
- Ribosomes translate it immediately after uncoating
- Product is one long polyprotein
- Viral protease cuts it into functional units
- Includes the viral RNA-dependent RNA polymerase
- Made de novo after entry
- Not packaged in the virion
- Genome RNA alone is infectious when introduced into a cell
Cycle in order
EntryβUncoatingβTranslation to polyproteinβProtease cleavageβPolymerase copies (+) to (β)β(β) templates make new (+)βAssemblyβRelease
- Naked members exit by lysing the cell
- All replication occurs in the cytoplasm, except retroviruses
Family comparison
| Family | Envelope | Shape | Examples |
|---|---|---|---|
| Calici | Naked | Icosahedral | Norovirus |
| Hepe | Naked | Icosahedral | Hepatitis E |
| Picorna | Naked | Icosahedral | Polio, coxsackie, echo, rhino, hepatitis A |
| Flavi | Enveloped | Icosahedral | Yellow fever, dengue, Zika, West Nile, St. Louis encephalitis, hepatitis C |
| Toga | Enveloped | Icosahedral | Rubella, equine encephalitis viruses, chikungunya |
| Corona | Enveloped | Helical | Seasonal coronaviruses, SARS, MERS, SARS-CoV-2 |
| Retro | Enveloped | Icosahedral or conical core | HIV, HTLV |
Exception
- Retroviruses carry two copies of the genome plus packaged reverse transcriptase and replicate through the nucleus.
- Their RNA alone cannot start an infection.
π¦ Naked Positive-Sense Viruses: Noro, Picorna
Norovirus (Caliciviridae)
- Reservoir: human gut
- Spread: fecal-oral, food, water, surfaces
- Outbreaks in cruise ships, schools, care homes
- Syndrome
- Vomiting, watery diarrhea, nausea
- Noninflammatory: no blood or pus
- Leading viral cause of nonbacterial gastroenteritis in adults
- Diagnosis: antigen or molecular assays
- Treatment: fluids, self-limited
- Prevention: handwashing, surface disinfection
Picornavirus family traits
- Very small, naked, icosahedral
- Resist alcohol and detergents
- Peak in summer and fall
- Genera
- Enteroviruses: acid-stable, fecal-oral, mostly children
- Rhinoviruses: acid-labile, grow best near 33 Β°C (nose)
- Hepatovirus: hepatitis A
- Enteroviruses rarely cause diarrhea despite the gut route
Picornavirus disease map
| Virus | Features |
|---|---|
| Poliovirus |
|
| Coxsackie A |
|
| Coxsackie B |
|
| Enterovirus D68 |
|
| Echovirus |
|
| Rhinovirus |
|
| Hepatitis A |
|
- Enterovirus therapy is supportive
- Pleconaril blocks uncoating, limited availability, needs early use
Exam trap
- Paralytic polio spares sensation because only motor neurons are destroyed.
- Acid stability separates enteroviruses from rhinoviruses.
π¦ Enveloped (+) RNA: Flavi, Toga, Corona
Flaviviruses (mostly arthropod-borne)
| Virus | Vector | Reservoir | Disease | Prevention |
|---|---|---|---|---|
| St. Louis encephalitis | Culex mosquito | Birds | Encephalitis | Vector control |
| West Nile | Culex mosquito | Birds (die-offs) | Encephalitis, flaccid paralysis | Vector control |
| Dengue | Aedes mosquito | Humans, primates |
| Vector control |
| Yellow fever | Aedes mosquito | Humans, primates |
| Live attenuated vaccine |
| Zika | Aedes; also sexual and vertical | Vertebrates |
| Vector control, safe sex |
- Diagnosis: serology, PCR; treatment: supportive
- Hepatitis C is also a flavivirus (see hepatitis notes)
Togaviruses
| Virus | Key points |
|---|---|
| Eastern, Western, Venezuelan equine encephalitis |
|
| Chikungunya |
|
| Rubella |
|
Congenital rubella
- Worst when maternal infection falls in the first trimester
- Cardiac: patent ductus arteriosus, pulmonary artery stenosis
- Eye: cataracts
- Ear: sensorineural deafness
- CNS: microcephaly, developmental delay
Coronaviruses
- Enveloped, helical, large (+) RNA genome
- Spike glycoprotein gives the crown appearance
- Host receptor: ACE2 (for SARS-CoV and SARS-CoV-2)
- Seasonal strains: second most common cause of colds, winter-spring
SARS-CoV
- Animal reservoir (civets, bats); droplet spread
- Atypical pneumonia: fever, dry cough, dyspnea, hypoxia
- Patchy interstitial infiltrates
- Linked to travel to affected regions
- Diagnosis: RT-PCR, antibody, culture
- Treatment: supportive
SARS-CoV-2 (COVID-19)
- Droplet and aerosol spread; asymptomatic carriers contribute
- Higher severity in elderly and immunocompromised
- Incubation about 4β14 days
- Systemic: fever, chills, myalgia, fatigue, headache
- Respiratory: cough, sore throat, congestion, dyspnea, loss of smell or taste
- GI symptoms possible
- Severe: bilateral infiltrates, ARDS, ventilation
- Diagnosis
- Nucleic acid amplification (RT-PCR) is most sensitive
- Antigen tests: faster, less sensitive
- Serology shows past exposure
- Treatment by severity
- Mild: supportive
- Hospitalized: remdesivir (adenosine analog), dexamethasone if oxygen needed
- Prevention
- Masks, distancing, isolation of exposed persons
- Vaccines: mRNA, adenoviral vector, protein nanoparticle; all target spike
MERS-CoV
- Reservoir: bats, camels
- Severe respiratory illness similar to SARS
Exam trap
- Culex transmits West Nile and St. Louis encephalitis; Aedes transmits dengue, yellow fever and Zika.
π©Έ Retroviruses and HIV
Retrovirus features
- Enveloped, diploid (+) RNA
- Virion carries reverse transcriptase
- Integrates as a DNA provirus
- Groups
- Oncoviruses: HTLV
- Lentiviruses: HIV
HTLV
- T-cell tropic; Tax protein drives transformation
- Adult T-cell leukemia with flower-shaped nuclei
- HTLV-1 associated myelopathy (spastic paraparesis)
- Endemic: Japan, Caribbean, South America
HIV virion parts
- Host-derived envelope with gp120 (surface) and gp41 (transmembrane)
- Matrix p17 under envelope
- Conical capsid p24
- Nucleocapsid p7/p9 around two RNA copies
- Enzymes: reverse transcriptase, integrase, protease
Cell entry
gp120 binds CD4βConformation change exposes coreceptor siteβCCR5 (macrophage-tropic) or CXCR4 (T-cell-tropic)βgp41 mediates fusion
- Targets: helper T cells, macrophages, microglia, dendritic cells
Gene functions
| Gene | Product | Role |
|---|---|---|
| gag | p24, p17, p7/p9 | Capsid, matrix, nucleocapsid |
| pol | Reverse transcriptase | Makes dsDNA provirus; error-prone, drives variation |
| pol | Integrase | Inserts viral DNA into host genome |
| pol | Protease | Cleaves polyproteins for maturation |
| env | gp120 | Receptor binding, tropism, antigenic variation |
| env | gp41 | Membrane fusion |
| LTR | Long terminal repeats | Promoter and integration sites |
| tat | Transactivator | Boosts transcription |
| rev | RNA transport protein | Exports unspliced RNA to cytoplasm |
| nef | Regulatory protein | Lowers CD4 and MHC I on host cells; needed for progression |
Host and viral variants
| Change | Effect |
|---|---|
| Defective nef | Slow or absent progression |
| Defective tat or rev | No replication |
| Defective vif | Slow progression |
| CCR5 loss, homozygous | Strong resistance to infection |
| CCR5 loss, heterozygous | Slower progression |
Replication of HIV
Attachment and fusionβUncoatingβReverse transcription to dsDNAβNuclear import with integraseβProvirus integratedβTranscription (tat boosts)βSpliced RNA to mRNA; unspliced to genomesβTranslation to polyproteinsβAssembly and buddingβProtease maturation
- Coinfections that activate immune cells increase viral output
Transmission and natural history
- Spread: sexual contact, blood exposure (needles, transfusion), vertical (birth, breastfeeding)
- Reservoir: helper T cells and macrophages
Acute retroviral syndromeβAsymptomatic phaseβPersistent lymphadenopathyβSymptomatic diseaseβAIDS
- Course tracks falling CD4 count; viral load tracks prognosis
Staging by CD4 count (age 6 and older)
| Stage | CD4 count | CD4 % |
|---|---|---|
| 1 | β₯ 500/Β΅L | β₯ 26% |
| 2 | 200β499/Β΅L | 14β25% |
| 3 (AIDS) | < 200/Β΅L | < 14% |
- Younger children use higher thresholds because normal counts are higher
- Any stage-3-defining opportunistic illness places the patient in stage 3 regardless of count
- Count takes priority over percentage
Early symptomatic conditions
- Oral thrush, recurrent vaginal candidiasis
- Oral hairy leukoplakia
- Bacillary angiomatosis
- Cervical dysplasia
- Prolonged fever or diarrhea
- Immune thrombocytopenia
- Listeriosis
- Pelvic inflammatory disease
- Peripheral neuropathy
AIDS-defining conditions
- Recurrent pneumonia; leading cause of death
- HIV encephalopathy; wasting
- Fungal
- Pneumocystis pneumonia
- Esophageal, bronchial or pulmonary candidiasis
- Disseminated coccidioidomycosis, histoplasmosis
- Extrapulmonary cryptococcosis
- Viral
- CMV retinitis or disseminated disease
- Chronic or invasive herpes simplex
- Progressive multifocal leukoencephalopathy
- Parasitic
- Cerebral toxoplasmosis
- Chronic cryptosporidiosis, isosporiasis
- Bacterial
- Tuberculosis at any site
- Disseminated Mycobacterium avium complex
- Recurrent nontyphoidal Salmonella bacteremia
- Cancers
- Kaposi sarcoma, invasive cervical carcinoma
- Primary CNS lymphoma, Burkitt and immunoblastic lymphoma
Prophylaxis thresholds
| Pathogen | Start below CD4 of |
|---|---|
| Pneumocystis jirovecii | 200 |
| Toxoplasma gondii | 100 |
| Histoplasma (endemic area) | 100 |
| M. avium complex | 50 |
| CMV | 50 |
| Cryptococcus | 50 |
Laboratory testing
| Goal | Test |
|---|---|
| Screening | Fourth-generation antigen/antibody immunoassay |
| Confirmation | HIV-1/HIV-2 differentiation assay; viral RNA test if unclear |
| Viral load, treatment monitoring | RT-PCR of plasma RNA |
| Infant of infected mother | PCR for proviral DNA or RNA |
| Earliest marker | p24 antigen |
| Disease progression | CD4 count, CD4:CD8 ratio |
- Maternal antibody crosses the placenta, so infant antibody tests mislead
Antiretroviral classes
| Class | Examples | Notes |
|---|---|---|
| Nucleoside/nucleotide RT inhibitors | Zidovudine, tenofovir, lamivudine | Zidovudine: marrow suppression, anemia |
| Non-nucleoside RT inhibitors | Efavirenz, nevirapine | Cross-resistance common |
| Protease inhibitors | Names end in -navir (ritonavir) | Fat redistribution, glucose and lipid changes, drug interactions |
| Integrase inhibitors | Raltegravir | High barrier to resistance |
| Fusion inhibitor | Enfuvirtide | Blocks gp41 |
| CCR5 antagonist | Maraviroc | Only for CCR5-tropic virus |
- Standard therapy combines several classes to prevent resistance
- No vaccine exists
- Prevention: safe sex, screening blood and organs, sterile needles, perinatal antiretrovirals
Exam trap
- RT-PCR measures circulating virus; proviral PCR detects integrated DNA.
- Oral hairy leukoplakia is an early marker, not an AIDS-defining illness.
π Negative-Sense RNA: Principles and Paramyxoviruses
Shared rules
- Genome is complementary to mRNA, so it cannot be translated directly
- Virion packs its own RNA-dependent RNA polymerase
- All are enveloped with helical nucleocapsids
- Replicate in the cytoplasm, except influenza (nucleus)
EntryβPolymerase transcribes (β) into mRNAsβProteins madeβFull-length (+) copyβNew (β) genomesβBudding
Family structure
| Family | Genome layout | Examples |
|---|---|---|
| Paramyxo | Linear, one piece | Measles, mumps, RSV, parainfluenza, metapneumovirus |
| Rhabdo | Linear, one piece; bullet shape | Rabies, vesicular stomatitis |
| Filo | Linear, one piece; filamentous | Ebola, Marburg |
| Orthomyxo | Linear, 8 segments | Influenza A, B |
| Bunya | Circular-like, 3 segments | California and LaCrosse encephalitis, hantavirus |
| Arena | Circular, 2 segments | LCMV, Lassa |
- Bunya and arena genomes contain ambisense segments
Measles
- Single serotype; hemagglutinin and fusion proteins; no neuraminidase
- Respiratory spread; extremely contagious
- Fusion causes multinucleated giant cells
- Illness
- Cough, coryza, conjunctivitis, photophobia
- Koplik spots in mouth
- Rash from head downward
- Giant-cell pneumonia (Warthin-Finkeldey cells)
- Subacute sclerosing panencephalitis
- Late complication, several years later
- Defective virus persists in brain
- Progressive neurodegeneration
- Diagnosis: serology
- Treatment: supportive; vitamin A in children
- Prevention: live attenuated MMR
Mumps
- Single serotype; HN and F glycoproteins
- Droplet spread; infects upper airway then parotids
- Parotitis, fever, malaise (some subclinical)
- Complications
- Orchitis, with possible infertility
- Pancreatitis
- Meningoencephalitis
- Diagnosis: clinical, serology, PCR
- Prevention: live attenuated MMR
Other paramyxoviruses
| Virus | Disease | Diagnosis | Management |
|---|---|---|---|
| Parainfluenza | Croup in children: subglottal swelling, barking cough, stridor; also colds, pneumonia | RT-PCR | Supportive; steroids and racemic epinephrine for croup |
| RSV | Infant bronchiolitis: bronchiolar necrosis, wheeze, tachypnea; adult colds; severe in premature infants | Antigen assay, RT-PCR | Supportive; palivizumab (anti-fusion protein antibody) prevents severe disease in high-risk infants; ribavirin in select cases |
| Human metapneumovirus | Colds, bronchiolitis, pneumonia | RT-PCR | Supportive |
Concept
- Paramyxovirus fusion proteins create syncytia, so infected cells merge into giant cells.
π Rabies, Filoviruses, Influenza
Rabies virus
- Bullet-shaped, enveloped, helical
- Reservoirs: bats, raccoons, skunks, foxes; dogs worldwide
- Spread: bite or contact with saliva of rabid animal
- Pathogenesis
- Replicates in muscle at the bite
- Binds nicotinic acetylcholine receptors on nerves
- Retrograde axonal transport to spinal cord and brain
- Clinical
- Flu-like prodrome, pain or tingling at bite
- Hydrophobia, agitation, seizures, hallucinations
- Coma and death
- Almost uniformly fatal once symptomatic
- Diagnosis
- Negri bodies (cytoplasmic inclusions) in brain neurons
- Direct fluorescent antibody on tissue or corneal smears
- PCR
- Postexposure prophylaxis
- Wound washing
- Human rabies immune globulin
- Inactivated vaccine series on days 0, 3, 7, 14
- Prevention: vaccinate pets; preexposure vaccine for high-risk workers
Filoviruses
- Enveloped, filamentous, helical
- Members: Ebola (Zaire species most lethal), Marburg
- Reservoir: bats (possible for Ebola, confirmed for Marburg)
- Spread: contact with blood or body fluids, handling infected animals or bushmeat
- Pathogenesis
- Macrophages and dendritic cells infected first
- Spread via lymph nodes to blood
- Cytokine storm, vascular leak, multi-organ failure
- Clinical
- Incubation about 6β12 days
- Fever, chills, malaise, headache
- Vomiting and diarrhea with major fluid loss
- Bleeding is possible but not dominant
- Rash, meningoencephalitis
- Diagnosis: exposure history, RT-PCR confirms
- Treatment: aggressive supportive care; monoclonal antibodies targeting glycoprotein
- Prevention: isolation and infection control; live recombinant vesicular stomatitis vaccine
Influenza virus
- Enveloped, 8 RNA segments, replicates in nucleus
- Surface proteins
- Hemagglutinin (H): attachment and fusion
- Neuraminidase (N): releases new virions
- Reservoirs
- Influenza A: birds, pigs, humans
- Influenza B: humans only
- Spread: droplets and contact
- Antigenic drift
- Point mutations in H and N
- Influenza A and B
- Causes seasonal epidemics
- Antigenic shift
- Influenza A only
- Cell coinfected with two strains; segments reassort
- Novel subtype with no population immunity
- Causes pandemics
- Example: 2009 H1N1 was a reassortant of swine, avian and human segments
- Clinical
- Abrupt fever, chills, headache, myalgia, cough, malaise
- Children: croup, otitis media, vomiting
- Complications: secondary bacterial pneumonia, myocarditis
- Associations: Reye syndrome (aspirin), Guillain-BarrΓ© syndrome
- Diagnosis: rapid antigen or PCR testing plus season
- Treatment
- Neuraminidase inhibitors: oseltamivir (oral), zanamivir (inhaled)
- M2 blockers (amantadine, rimantadine): most strains now resistant
- Prevention
- Annual inactivated vaccine, updated each year
- Live intranasal vaccine exists but is not generally recommended
Exam trap
- Drift happens in both A and B; shift and pandemics are influenza A only.
- Rabies is diagnosed by Negri bodies but treated before symptoms begin.
π Bunyaviruses, Arenaviruses, Reoviruses
Bunyaviridae
- Enveloped, 3 segments (one ambisense)
- Mostly arboviruses, hantavirus is the exception (rodent-borne)
| Virus | Spread | Disease | Diagnosis |
|---|---|---|---|
| California and LaCrosse | Mosquito | Viral encephalitis, mainly in children | Serology |
| Hantavirus (Sin Nombre) | Inhaled rodent excreta; southwestern U.S. |
| RT-PCR |
Arenaviridae
- Pleomorphic, enveloped, 2 segments (one ambisense)
- Sandy appearance from host ribosomes in virion
| Virus | Spread | Disease | Treatment |
|---|---|---|---|
| Lymphocytic choriomeningitis | Mice and pet hamsters | Flu-like illness with aseptic meningitis | Supportive, ribavirin |
| Lassa fever | Rodents, then person to person (West Africa) | Hemorrhagic fever, high fatality, deafness | Supportive, ribavirin |
- Lassa needs high-containment handling
Reoviridae (double-stranded RNA)
- Only RNA virus family with a double-stranded genome
- Naked, icosahedral, double protein shell
- 10β12 genome segments; packaged RNA polymerase
- Segmentation permits reassortment
- Members: reovirus, rotavirus, Colorado tick fever virus
| Virus | Spread | Disease | Diagnosis | Prevention |
|---|---|---|---|---|
| Reovirus | Fecal-oral, respiratory | Mild cold-like or gastrointestinal illness | Serology | None needed |
| Rotavirus | Fecal-oral | Infant watery diarrhea, dehydration, no blood or pus | Stool antigen assay | Live attenuated oral vaccine |
| Colorado tick fever virus | Tick bite | Biphasic fever, myalgia | Serology, PCR | Tick avoidance |
- Rotavirus is the leading cause of severe diarrhea in young children
- Treatment centers on oral or IV rehydration
High-yield
- Rotavirus vaccine is given by mouth, not injection.
π§ Prions and Slow Infections
Prion biology
- Infectious protein with no nucleic acid
- Extremely resistant to heat, radiation, standard disinfectants and protease
- Normal form: PrPC
- Made by neurons, sits on cell surface
- Gene on chromosome 20
- Protease-sensitive, mostly alpha-helical
- Abnormal form: PrPSc
- Misfolded, beta-sheet rich
- Protease-resistant, aggregates
Conversion chain
PrPSc contacts PrPCβPrPC refolds to PrPScβMore PrPSc templates moreβAggregates build in neuronsβVacuoles, neuron lossβSpongiform encephalopathy
- No inflammatory response and no antibody response
- Brain shows vacuolation, gliosis, no inflammation
- No effective treatment; always fatal
Human and animal prion diseases
| Disease | Host | Notes |
|---|---|---|
| Kuru | Human | Ritual cannibalism, Papua New Guinea highlands |
| Creutzfeldt-Jakob disease | Human |
|
| Gerstmann-StrΓ€ussler-Scheinker | Human | Inherited, ataxia then dementia |
| Fatal familial insomnia | Human | Inherited, thalamic degeneration, intractable insomnia |
| Scrapie | Sheep | Animals scratch against objects |
Slow conventional virus infections
| Condition | Agent | Setting |
|---|---|---|
| Subacute sclerosing panencephalitis | Defective measles virus | Years after early measles infection |
| HIV-associated dementia | HIV (microglia) | Advanced immunodeficiency |
| Progressive multifocal leukoencephalopathy | JC polyomavirus | AIDS, transplant, immunomodulator therapy; oligodendrocyte destruction |
Exam trap
- Prions are not destroyed by routine autoclaving, so specialized sterilization is required.
- Viral slow infections are true viruses with nucleic acid; prions are not.